1 HE Lebovitz (2006) Insulin resistance – a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 8, 237–249.
2 N Kahn & H Mukhtar (2007) Tea polyphenols for health promotion. Life Sci 81, 519–533.
3 YH Kao , HH Chang , MJ Lee & CL Chen (2006) Tea, obesity, and diabetes. Mol Nutr Food Res 50, 188–210.
4 T Murase , A Nagasawa , J Suzuki , T Hase & I Tokimitsu (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes 26, 1459–1464.
5 LY Wu , CC Juan , LS Hwang , YP Hsu , PH Ho & LT Ho (2004) Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr 43, 116–124.
6 LY Wu , CC Juan , LT Ho , YP Hsu & LS Hwang (2004) Effect of green tea supplementation on insulin sensitivity in Sprague–Dawley rats. J Agric Food Chem 52, 643–648.
7 K Hosoda , MF Wang , ML Liao , CK Chuang , M Iha , B Clevidence & S Yamamoto (2003) Antihyperglycentic effect of oolong tea in type 2 diabetes. Diabetes Care 26, 1714–1718.
8 H Tsuneki , M Ishizuka , M Terasawa , JB Wu , T Sasaoka & I Kimura (2004) Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 4, 18.
9 CL Broadhurst , MM Polansky & RA Anderson (2000) Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 48, 849–852.
10 RA Anderson & MM Polansky (2002) Tea enhances insulin activity. J Agric Food Chem 50, 7182–7186.
11 MA Potenza , FL Marasciulo , M Tarquinio , E Tiravanti , G Colantuono , A Federici , JA Kim , MJ Quon & M Montagnani (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292, E1378–E1387.
13 PC Chen , DS Wheeler , V Malhotra , K Odoms , AG Denenberg & HR Wong (2002) A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits I kappa B kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 26, 233–241.
16 SE Shoelson , J Lee & M Yuan (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes 27, S49–S52.
17 Y Tamura , T Ogihara , T Uchida , (2007) Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappa B in db/db mice. Diabetologia 50, 131–141.
18 N Adachi , S Tomonaga , T Tachibana , DM Denbow & M Furuse (2006) ( − )-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531, 171–175.
19 M Vignes , T Maurice , F Lante , M Nedjar , K Thethi , J Guiramand & M Recasens (2006) Anxiolytic properties of green tea polyphenol ( − )-epigallocatechin gallate (EGCG). Brain Res 1110, 102–115.
20 DR Matthews , JP Hosker , AS Rudenski , BA Naylor , DF Treacher & RC Turner (1985) Homeostasis model assessment – insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia 28, 412–419.
21 M Matsuda & RA DeFronzo (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing – comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462–1470.
22 DIW Phillips , PM Clark , CN Hales & C Osmond (1994) Understanding oral glucose-tolerance – comparison of glucose or insulin measurements during the oral glucose-tolerance test with specific measurements of insulin-resistance and insulin-secretion. Diabetes Med 11, 286–292.
23 GM Price , AA Paul , FB Key , AC Harter , TJ Cole , KC Day & MEJ Wadsworth (1995) Measurement of diet in a large national survey: comparison of computerised and manual coding in household measures. J Hum Nutr Diet 8, 417–428.
25 G Matthews , DM Jones & AG Chamberlain (1990) Refining the measurement of mood – the UWIST mood adjective checklist. Br J Psychol 81, 17–42.
26 J Svedlund , I Sjodin & G Dotevall (1988) GSRS – a clinical rating-scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic-ulcer disease. Digest Dis Sci 33, 129–134.
29 S Khokhar & SGM Magnusdottir (2002) Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50, 565–570.
30 Y Fukino , M Shimbo , N Aoki , T Okubo & H Iso (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol 51, 335–342.
32 CCW Chan , MWL Koo , EHY Ng , OS Tang , WSB Yeung & PC Ho (2006) Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome – a randomized placebo-controlled trial. J Soc Gynecol Invest 13, 63–68.
33 OH Ryu , J Lee , KW Lee , HY Kim , JA Seo , SG Kim , NH Kim , SH Baik , DS Choi & KM Choi (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Prac 71, 356–358.
34 WY Feng (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7, 755–809.
35 ME Waltner-Law , XHL Wang , BK Law , RK Hall , M Nawano & DK Granner (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933–34940.
36 NR Cook , J Cohen , PR Hebert , JO Taylor & CH Hennekens (1995) Implications of small reductions in diastolic blood-pressure for primary prevention. Arch Intern Med 155, 701–709.
37 YC Yang , FH Lu , JS Wu , CH Wu & CJ Chang (2004) The protective effect of habitual tea consumption on hypertension. Arch Intern Med 164, 1534–1540.
38 JP Henry & P Stephenslarson (1984) Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 6, 437–444.
40 M Lorenz , S Wessler , E Follmann , W Michaelis , T Dusterhoft , G Baumann , K Stangl & V Stangl (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279, 6190–6195.
41 IA Persson , M Josefsson , K Persson & RG Andersson (2006) Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 58, 1139–1144.
42 JA Kim , G Formoso , YH Li , MA Potenza , FL Marasciulo , M Montagnani & MJ Quon (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282, 13736–13745.
43 F Kim , KA Tysseling , J Rice , B Gallis , L Haji , CM Giachelli , EW Raines , MA Corson & MW Schwartz (2005) Activation of IKK beta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells. J Mol Cell Cardiol 39, 327–334.
44 F Kim , KA Tysseling , J Rice , (2005) Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKK beta. Arterioscler Thromb Vasc Biol 25, 989–994.
45 MH Pan , SY Lin-Shiau , CT Ho , JH Lin & JK Lin (2000) Suppression of lipopolysaccharide-induced nuclear factor-kappa B activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of I kappa B kinase activity in macrophages. Biochem Pharmacol 59, 357–367.
46 WJ Tang , CP Hu , MF Chen , PY Deng & YJ Li (2006) Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharm 84, 163–171.
47 ME Widlansky , NM Hamburg , E Anter , M Holbrook , DF Kahn , JG Elliott , JF Keaney & JA Vita (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26, 95–102.
49 N Nagaya , H Yamamoto , M Uematsu , T Itoh , K Nakagawa , T Miyazawa , K Kangawa & K Miyatake (2004) Green tea reverses endothelial dysfunction in healthy smokers. Heart 90, 1485–1486.
50 C Heiss , H Schroeter , J Balzer , P Kleinbongard , S Matern , H Sies & M Kelm (2006) Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharm 47, S128–S135.
51 M Suganuma , S Okabe , M Oniyama , Y Tada , H Ito & H Fujiki (1998) Wide distribution of [H-3]( − )-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771–1776.
52 AC Paladini , M Marder , H Viola , C Wolfman , C Wasowski & JH Medina (1999) Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds. J Pharm Pharmacol 51, 519–526.
53 A Steptoe , EL Gibson , R Vounonvirta , ED Williams , M Hamer , JA Rycroft , JD Erusalimsky & J Wardle (2007) The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial. Psychopharmacology 190, 81–89.
55 D Grassi , S Necozione , C Lippi , G Croce , L Valeri , P Pasqualetti , G Desideri , JB Blumberg & C Ferri (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398–405.